These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7989388)

  • 41. Intralesional curettage for grades II and III giant cell tumors of bone.
    Lackman RD; Hosalkar HS; Ogilvie CM; Torbert JT; Fox EJ
    Clin Orthop Relat Res; 2005 Sep; 438():123-7. PubMed ID: 16131880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
    Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
    Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Giant cell tumor of bone. An evaluation of 87 patients].
    Tunn PU; Schlag PM
    Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Giant-cell tumor of bone around the knee.
    Fong YC; Chen TH; Chen WM; Lo WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):240-7. PubMed ID: 9216120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Meta-analysis of risk factors of recurrence in patients with giant cell tumor on extremities].
    Li R; Hu Y
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(47):3778-83. PubMed ID: 25623108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethanol as a local adjuvant for giant cell tumor of bone.
    Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
    Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
    Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
    BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconstruction of the distal aspect of the radius with use of an osteoarticular allograft after excision of a skeletal tumor.
    Kocher MS; Gebhardt MC; Mankin HJ
    J Bone Joint Surg Am; 1998 Mar; 80(3):407-19. PubMed ID: 9531209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
    Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Giant cell tumor of bone. Curettage and cement reconstruction.
    Bini SA; Gill K; Johnston JO
    Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
    Errani C; Tsukamoto S; Leone G; Righi A; Akahane M; Tanaka Y; Donati DM
    J Bone Joint Surg Am; 2018 Mar; 100(6):496-504. PubMed ID: 29557866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases.
    Hoch B; Inwards C; Sundaram M; Rosenberg AE
    J Bone Joint Surg Am; 2006 Sep; 88(9):1998-2008. PubMed ID: 16951117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does curettage-cement packing for treating giant cell tumors at the knee lead to osteoarthritis?
    Caubère A; Harrosch S; Fioravanti M; Curvale G; Rochwerger A; Mattei JC
    Orthop Traumatol Surg Res; 2017 Nov; 103(7):1075-1079. PubMed ID: 28782699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients.
    Tejwani SG; Hame SL; Eckardt JJ
    Arthroscopy; 2004 Jul; 20(6):644-9. PubMed ID: 15241319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aneurysmal bone cyst of the extremities. Factors related to local recurrence after curettage with a high-speed burr.
    Gibbs CP; Hefele MC; Peabody TD; Montag AG; Aithal V; Simon MA
    J Bone Joint Surg Am; 1999 Dec; 81(12):1671-8. PubMed ID: 10608377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
    van der Heijden L; van de Sande MA; Heineken AC; Fiocco M; Nelissen RG; Dijkstra PD
    J Bone Joint Surg Am; 2013 Nov; 95(21):e159. PubMed ID: 24196471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.
    Gao ZH; Yin JQ; Xie XB; Zou CY; Huang G; Wang J; Shen JN
    BMC Musculoskelet Disord; 2014 Oct; 15():330. PubMed ID: 25277133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Giant cell tumour of bone.
    Aoude A; Nikomarov D; Perera JR; Ibe IK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS
    Bone Joint J; 2023 May; 105-B(5):559-567. PubMed ID: 37121582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iterative curettage is associated with local control in giant cell tumors involving the distal tibia.
    AlSulaimani SA; Turcotte RE;
    Clin Orthop Relat Res; 2013 Aug; 471(8):2668-74. PubMed ID: 23568675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.